Forte Biosciences Q1 2026 Earnings Prerevenue Biotech Misses EPS Estimates Stock Dips on Narrower Loss Miss Molecular Partners Q4 2025 Earnings EPS Beat Drives Shares Higher Amid Clinical Progress DBD Q1 2026 Earnings EPS Beats Estimates Shares Rise on Profitability Strength MAR Q1 2026 Earnings Strong EPS Beat Amid Market Skepticism BDSX Q1 2026 Earnings EPS Surprises to the Upside Amid Operational Progress Altisource ASPSW Stock Entry Strategy Overview PNC Q1 2026 Earnings Modest EPS Beat Reflects Resilient Core Operations